Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug composition for preventing and treating related diseases of ischemic stroke as well as preparation method and applications thereof

A technology for ischemic stroke and composition, applied in the field of medicine, can solve the problem that the active ingredients of the compound Xueshuantong preparation are not clear enough, and achieve the effects of improving the microcirculation of the auricle, being beneficial to the production cost and being highly controllable.

Active Publication Date: 2014-11-19
GUANGDONG ZHONGSHENG PHARMA
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to provide a pharmaceutical composition for preventing and treating diseases related to ischemic stroke, aiming to solve the problem that the active ingredients of compound Xueshuantong preparation are not clear enough

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug composition for preventing and treating related diseases of ischemic stroke as well as preparation method and applications thereof
  • Drug composition for preventing and treating related diseases of ischemic stroke as well as preparation method and applications thereof
  • Drug composition for preventing and treating related diseases of ischemic stroke as well as preparation method and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] The preparation of embodiment one pharmaceutical composition

[0027] Weigh 27g notoginsenoside R 1 , 69g ginsenoside Rg 1 , 62g ginsenoside Rb 1, 21g ginsenoside Re, 0.4g astragaloside IV, 0.038g calycosin-7-O-β-D-glucopyranoside, 0.36g harpagoside, 0.039g cinnamic acid, 10g salvianolic acid B, 0.24g crypto Tanshinone and 0.28g tanshinone IIA were mixed uniformly to obtain a pharmaceutical composition.

Embodiment 2

[0028] The preparation of embodiment two pharmaceutical compositions

[0029] Weigh 15g notoginsenoside R 1 , 52g ginsenoside Rg 1 , 46g ginsenoside Rb 1 , 17g ginsenoside Re, 1.1g astragaloside IV, 0.06g calycosin-7-O-β-D-glucopyranoside, 0.18g harpagoside, 0.022g cinnamic acid, 7.2g salvianolic acid B, 0.47g Cryptotanshinone and 0.5 tanshinone IIA are mixed evenly to obtain a pharmaceutical composition.

Embodiment 3

[0030] The preparation of embodiment three pharmaceutical compositions

[0031] Weigh 21g notoginsenoside R 1 , 58g ginsenoside Rg 1 , 52g ginsenoside Rb 1 , 17g ginsenoside Re, 1.1g astragaloside IV, 0.07g calycosin-7-O-β-D-glucopyranoside, 0.48g harpagoside, 0.042g cinnamic acid, 7.7g salvianolic acid B, 0.47g Cryptotanshinone, 0.49g of tanshinone IIA and 0.51g of tanshinone I were mixed uniformly to obtain a pharmaceutical composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention is suitable for the field of medicines and provides a drug composition for preventing and treating related diseases of ischemic stroke. The drug composition comprises the following components in parts: 1.0-3.5 parts of notoginsenoside R1, 4.0-7.5 parts of ginsenoside Rg1, 3.5-7.5 parts of ginsenoside Rb1, 1.0-3.0 parts of ginsenoside Re, 0.03-0.15 part of astragaloside, 0.02-0.010 part of calycosin-7-O-beta-D-glucopyranoside, 0.01-0.10 part of harpagoside, 0.002-0.010 part of cinnamic acid, 0.45-1.5 parts of salvianolic acid B, 0.02-0.10 part of cryptotanshinone and 0.02-0.10 part of tanshinone IIA. The drug composition provided by the invention has the functions of promoting blood circulation and removing blood stasis, supplementing qi and nourishing yin, can be used for preventing and treating the related diseases of the ischemic stroke and is capable of overcoming the shortcomings of component complexity and the like of traditional compound traditional Chinese medicine preparations.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for preventing and treating diseases related to ischemic stroke, a preparation method and application thereof. Background technique [0002] Compound Xueshuantong preparation is a pure traditional Chinese medicine preparation made from four medicinal materials of Sanqi, Danshen, Astragalus, and Scrophulariae. It has the functions of promoting blood circulation and removing blood stasis, nourishing qi and nourishing yin, dilating blood vessels, and improving blood circulation and microcirculation. Compound Xueshuantong preparations include Fufang Xueshuantong Capsules, Compound Xueshuantong Tablets, Compound Xueshuantong Soft Capsules, Compound Xueshuantong Granules, and Compound Xueshuantong Dropping Pills. The key for compound Xueshuantong preparation to exert its functions of promoting blood circulation, removing blood stasis, nourishin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61P9/10A61K31/704A61K31/58
Inventor 谢称石龙超峰杜静黄爱君
Owner GUANGDONG ZHONGSHENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com